D'AMBROSIO, SIMEONE
 Distribuzione geografica
Continente #
AS - Asia 41
EU - Europa 33
NA - Nord America 23
SA - Sud America 8
AF - Africa 1
Totale 106
Nazione #
US - Stati Uniti d'America 23
SG - Singapore 18
RU - Federazione Russa 16
CN - Cina 8
BR - Brasile 6
VN - Vietnam 6
DE - Germania 5
IT - Italia 5
HK - Hong Kong 3
AR - Argentina 2
FI - Finlandia 2
GB - Regno Unito 2
IN - India 2
JP - Giappone 2
DZ - Algeria 1
FR - Francia 1
GR - Grecia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 106
Città #
Singapore 8
Council Bluffs 5
Moscow 4
San Jose 4
Beijing 3
Hong Kong 3
Naples 3
Boardman 2
Ho Chi Minh City 2
Los Angeles 2
Munich 2
Shanghai 2
Tokyo 2
Turku 2
Angri 1
Athens 1
Balneário Arroio do Silva 1
Bengaluru 1
Cuiabá 1
Da Nang 1
Dallas 1
Düsseldorf 1
Falkenstein 1
Formosa 1
Frankfurt am Main 1
Hanoi 1
Itu 1
Kochi 1
Konya 1
Lauterbourg 1
Lavras 1
Lomas de Zamora 1
London 1
New York 1
Orem 1
Orlando 1
Porto Alegre 1
Rio Brilhante 1
Rochdale 1
Secaucus 1
Spring Valley 1
Tashkent 1
Tlemcen 1
Totale 73
Nome #
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis 103
Performance of Control Arms in Trials Leading to FDA Cancer Drug Approvals 4
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis 3
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma 1
Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study 1
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study 1
Totale 113
Categoria #
all - tutte 318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202535 0 0 0 0 0 0 4 2 4 6 14 5
2025/202678 4 3 11 3 11 5 5 3 11 8 14 0
Totale 113